The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 3
  • 1
    Aslam, Parvez
    Pharmacist born in December 1960
    Individual (4 offsprings)
    Officer
    2002-04-18 ~ now
    OF - director → CIF 0
    Aslam, Parvez
    Individual (4 offsprings)
    Officer
    2012-06-19 ~ now
    OF - secretary → CIF 0
  • 2
    Mclaren, Gavin David Callum
    Director born in January 1972
    Individual (5 offsprings)
    Officer
    2002-04-18 ~ now
    OF - director → CIF 0
  • 3
    Suite 4, Pavilion 3, St James Business Park, 81 Linwood Road, Paisley, Scotland
    Corporate (2 parents, 1 offspring)
    Equity (Company account)
    6,998,934 GBP2024-03-31
    Person with significant control
    2021-02-22 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
Ceased 7
  • 1
    Mclaren, Andrew Hugh
    Pharmaceutical Wholesaler born in June 1976
    Individual (2 offsprings)
    Officer
    2002-04-18 ~ 2004-04-06
    OF - director → CIF 0
  • 2
    O'brien, Joanne
    Accountant
    Individual
    Officer
    2002-04-18 ~ 2008-09-16
    OF - secretary → CIF 0
    Obrien, Joanne
    Individual
    Officer
    2010-11-05 ~ 2012-06-19
    OF - secretary → CIF 0
  • 3
    Mclaren, Stewart Mcintosh
    Pharmacist born in August 1946
    Individual
    Officer
    2002-04-18 ~ 2004-04-06
    OF - director → CIF 0
  • 4
    Aslam, Parvez
    Pharmacist
    Individual (4 offsprings)
    Officer
    2008-09-16 ~ 2010-11-05
    OF - secretary → CIF 0
    Mr Parvez Aslam
    Born in November 1960
    Individual (4 offsprings)
    Person with significant control
    2016-04-06 ~ 2021-02-17
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 5
    Mr Gavin David Callum Mclaren
    Born in January 1972
    Individual (5 offsprings)
    Person with significant control
    2016-04-06 ~ 2021-02-22
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
  • 6
    5 Logie Mill Beaverbank Office Park, Logie Green Road, Edinburgh
    Dissolved corporate (1 parent, 6 offsprings)
    Equity (Company account)
    2 GBP2022-02-28
    Officer
    2002-04-18 ~ 2002-04-18
    PE - nominee-secretary → CIF 0
  • 7
    14 Mitchell Lane, Glasgow
    Dissolved corporate (2 parents, 4 offsprings)
    Officer
    2002-04-18 ~ 2002-04-18
    PE - nominee-director → CIF 0
parent relation
Company in focus

CENTRAL PHARMACIES (UK) LIMITED

Standard Industrial Classification
47730 - Dispensing Chemist In Specialised Stores
Brief company account
Par Value of Share
Class 1 ordinary share
12023-03-31 ~ 2024-03-30
Turnover/Revenue
10,104,532 GBP2023-03-31 ~ 2024-03-30
8,271,296 GBP2022-03-31 ~ 2023-03-30
Cost of Sales
8,226,903 GBP2023-03-31 ~ 2024-03-30
6,598,645 GBP2022-03-31 ~ 2023-03-30
Gross Profit/Loss
1,877,629 GBP2023-03-31 ~ 2024-03-30
1,672,651 GBP2022-03-31 ~ 2023-03-30
Administrative Expenses
730,551 GBP2023-03-31 ~ 2024-03-30
399,550 GBP2022-03-31 ~ 2023-03-30
Operating Profit/Loss
1,153,078 GBP2023-03-31 ~ 2024-03-30
1,279,101 GBP2022-03-31 ~ 2023-03-30
Other Interest Receivable/Similar Income (Finance Income)
27,810 GBP2023-03-31 ~ 2024-03-30
12,680 GBP2022-03-31 ~ 2023-03-30
Interest Payable/Similar Charges (Finance Costs)
94,477 GBP2023-03-31 ~ 2024-03-30
16,381 GBP2022-03-31 ~ 2023-03-30
Profit/Loss on Ordinary Activities Before Tax
1,086,411 GBP2023-03-31 ~ 2024-03-30
1,275,400 GBP2022-03-31 ~ 2023-03-30
Tax/Tax Credit on Profit or Loss on Ordinary Activities
323,427 GBP2023-03-31 ~ 2024-03-30
247,055 GBP2022-03-31 ~ 2023-03-30
Profit/Loss
762,984 GBP2023-03-31 ~ 2024-03-30
1,028,345 GBP2022-03-31 ~ 2023-03-30
Comprehensive Income/Expense
762,984 GBP2023-03-31 ~ 2024-03-30
1,028,345 GBP2022-03-31 ~ 2023-03-30
Intangible Assets
2,415,834 GBP2024-03-30
Property, Plant & Equipment
551,973 GBP2024-03-30
478,940 GBP2023-03-30
Fixed Assets - Investments
100 GBP2024-03-30
100 GBP2023-03-30
Fixed Assets
2,967,907 GBP2024-03-30
479,040 GBP2023-03-30
Total Inventories
438,895 GBP2024-03-30
339,541 GBP2023-03-30
Debtors
2,572,538 GBP2024-03-30
2,802,868 GBP2023-03-30
Cash at bank and in hand
2,424,025 GBP2024-03-30
2,164,604 GBP2023-03-30
Current Assets
5,435,458 GBP2024-03-30
5,307,013 GBP2023-03-30
Creditors
Current
1,987,204 GBP2024-03-30
1,482,519 GBP2023-03-30
Net Current Assets/Liabilities
3,448,254 GBP2024-03-30
3,824,494 GBP2023-03-30
Total Assets Less Current Liabilities
6,416,161 GBP2024-03-30
4,303,534 GBP2023-03-30
Net Assets/Liabilities
4,488,635 GBP2024-03-30
3,913,651 GBP2023-03-30
Equity
Called up share capital
355,000 GBP2024-03-30
355,000 GBP2023-03-30
355,000 GBP2022-03-30
Retained earnings (accumulated losses)
4,133,635 GBP2024-03-30
3,558,651 GBP2023-03-30
2,618,306 GBP2022-03-30
Equity
4,488,635 GBP2024-03-30
3,913,651 GBP2023-03-30
2,973,306 GBP2022-03-30
Dividends Paid
Retained earnings (accumulated losses)
-188,000 GBP2023-03-31 ~ 2024-03-30
-88,000 GBP2022-03-31 ~ 2023-03-30
Dividends Paid
-188,000 GBP2023-03-31 ~ 2024-03-30
-88,000 GBP2022-03-31 ~ 2023-03-30
Comprehensive Income/Expense
Retained earnings (accumulated losses)
762,984 GBP2023-03-31 ~ 2024-03-30
1,028,345 GBP2022-03-31 ~ 2023-03-30
Wages/Salaries
1,296,190 GBP2023-03-31 ~ 2024-03-30
997,269 GBP2022-03-31 ~ 2023-03-30
Social Security Costs
92,322 GBP2023-03-31 ~ 2024-03-30
74,781 GBP2022-03-31 ~ 2023-03-30
Pension & Other Post-employment Benefit Costs/Other Pension Costs
20,553 GBP2023-03-31 ~ 2024-03-30
15,604 GBP2022-03-31 ~ 2023-03-30
Staff Costs/Employee Benefits Expense
1,409,065 GBP2023-03-31 ~ 2024-03-30
1,087,654 GBP2022-03-31 ~ 2023-03-30
Average Number of Employees
662023-03-31 ~ 2024-03-30
532022-03-31 ~ 2023-03-30
Director Remuneration
32,597 GBP2023-03-31 ~ 2024-03-30
33,936 GBP2022-03-31 ~ 2023-03-30
Property, Plant & Equipment - Depreciation Expense
Owned assets
37,558 GBP2023-03-31 ~ 2024-03-30
41,302 GBP2022-03-31 ~ 2023-03-30
Audit Fees/Expenses
6,000 GBP2023-03-31 ~ 2024-03-30
Current Tax for the Period
299,050 GBP2023-03-31 ~ 2024-03-30
245,369 GBP2022-03-31 ~ 2023-03-30
Intangible Assets - Gross Cost
Net goodwill
6,424,820 GBP2024-03-30
3,824,819 GBP2023-03-30
Intangible Assets - Accumulated Amortisation & Impairment
Net goodwill
4,008,986 GBP2024-03-30
3,824,819 GBP2023-03-30
Intangible Assets - Increase From Amortisation Charge for Year
Net goodwill
184,167 GBP2023-03-31 ~ 2024-03-30
Intangible Assets
Net goodwill
2,415,834 GBP2024-03-30
Property, Plant & Equipment - Gross Cost
Land and buildings
307,557 GBP2024-03-30
307,557 GBP2023-03-30
Improvements to leasehold property
18,300 GBP2024-03-30
18,300 GBP2023-03-30
Furniture and fittings
634,868 GBP2024-03-30
611,072 GBP2023-03-30
Property, Plant & Equipment - Gross Cost
1,047,520 GBP2024-03-30
936,929 GBP2023-03-30
Motor vehicles
86,795 GBP2024-03-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Improvements to leasehold property
17,375 GBP2024-03-30
17,144 GBP2023-03-30
Furniture and fittings
478,172 GBP2024-03-30
440,845 GBP2023-03-30
Property, Plant & Equipment - Accumulated Depreciation & Impairment
495,547 GBP2024-03-30
457,989 GBP2023-03-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Improvements to leasehold property
231 GBP2023-03-31 ~ 2024-03-30
Furniture and fittings
37,327 GBP2023-03-31 ~ 2024-03-30
Property, Plant & Equipment - Increase From Depreciation Charge for Year
37,558 GBP2023-03-31 ~ 2024-03-30
Property, Plant & Equipment
Land and buildings
307,557 GBP2024-03-30
307,557 GBP2023-03-30
Improvements to leasehold property
925 GBP2024-03-30
1,156 GBP2023-03-30
Furniture and fittings
156,696 GBP2024-03-30
170,227 GBP2023-03-30
Motor vehicles
86,795 GBP2024-03-30
Merchandise
438,895 GBP2024-03-30
339,541 GBP2023-03-30
Trade Debtors/Trade Receivables
Current
715,218 GBP2024-03-30
758,026 GBP2023-03-30
Other Debtors
Current
5,518 GBP2024-03-30
258,320 GBP2023-03-30
Amount of value-added tax that is recoverable
Current
195,032 GBP2024-03-30
170,278 GBP2023-03-30
Prepayments/Accrued Income
Current
51,035 GBP2024-03-30
10,509 GBP2023-03-30
Debtors
Amounts falling due within one year, Current
966,803 GBP2024-03-30
1,197,133 GBP2023-03-30
Bank Borrowings/Overdrafts
Current
269,872 GBP2024-03-30
135,772 GBP2023-03-30
Finance Lease Liabilities - Total Present Value
Current
4,373 GBP2024-03-30
Trade Creditors/Trade Payables
Current
1,212,686 GBP2024-03-30
914,123 GBP2023-03-30
Corporation Tax Payable
Current
299,050 GBP2024-03-30
245,369 GBP2023-03-30
Other Taxation & Social Security Payable
Current
32,390 GBP2024-03-30
19,681 GBP2023-03-30
Other Creditors
Current
2,958 GBP2024-03-30
1,250 GBP2023-03-30
Accrued Liabilities
Current
38,581 GBP2024-03-30
16,029 GBP2023-03-30
Bank Borrowings/Overdrafts
Non-current
1,795,301 GBP2024-03-30
353,662 GBP2023-03-30
Finance Lease Liabilities - Total Present Value
Non-current
71,627 GBP2024-03-30
Between one and five year, hire purchase agreements
71,627 GBP2024-03-30
hire purchase agreements
76,000 GBP2024-03-30
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
75,375 GBP2024-03-30
32,375 GBP2023-03-30
Between one and five year
256,500 GBP2024-03-30
129,500 GBP2023-03-30
More than five year
347,687 GBP2024-03-30
173,062 GBP2023-03-30
All periods
679,562 GBP2024-03-30
334,937 GBP2023-03-30
Amounts set aside to cover potential liabilities or losses
Deferred taxation
60,598 GBP2024-03-30
36,221 GBP2023-03-30
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
355,000 shares2024-03-30
Profit/Loss
Retained earnings (accumulated losses)
762,984 GBP2023-03-31 ~ 2024-03-30
Related profiles found in government register
  • CENTRAL PHARMACIES (UK) LIMITED
    Info
    Registered number SC230534
    Suite 4, Pavilion 3 St James Business Park, Linwood Road, Paisley PA3 3BB
    Private Limited Company incorporated on 2002-04-18 (23 years 1 month). The company status is Active.
    The last date of confirmation statement was made at 2025-04-12
    CIF 0
  • CENTRAL PHARMACIES (UK) LIMITED
    S
    Registered number Sc230534
    Room 24, Linwood Road, Linwood, Paisley, Scotland, PA3 3AT
    Private Limited Company in Companies House Uk, Scotland
    CIF 1
  • CENTRAL PHARMACIES (UK) LIMITED
    S
    Registered number Sc230534
    Suite 4, Paviloin 3, St James Business Park, 81 Linwood Road, Paisley, Scotland, PA3 3BB
    Private Company Limited By Shares in Scotland
    CIF 2
child relation
Offspring entities and appointments
Active 2
  • 1
    Suite 4, Pavilion 3 St James Business Park, Linwood Road, Paisley, United Kingdom
    Corporate (3 parents)
    Equity (Company account)
    -1,170 GBP2024-03-31
    Person with significant control
    2017-09-04 ~ now
    CIF 2 - Ownership of shares – 75% or more → OE
    CIF 2 - Ownership of voting rights - 75% or more → OE
  • 2
    Ra Accountant Llp, 2nd Floor, Grove House, 55, Lowlands Road, Harrow, England
    Corporate (2 parents)
    Person with significant control
    2023-07-25 ~ now
    CIF 1 - Ownership of shares – 75% or more → OE
    CIF 1 - Ownership of voting rights - 75% or more → OE
    CIF 1 - Right to appoint or remove directors → OE

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.